Daniel M. Halperin, MD

Daniel M. Halperin, MD

Specialty: Medical Oncology

MD Anderson Cancer Center

Multidisciplinary NET treatment program

1400 Holcombe Blvd. Unit 426
Houston, Texas

Patient scheduling: 866-508-0179

Online bio
100% of practice is NET patients
10 years’ experience treating NETs
23 published NET-related research papers

Daniel M. Halperin, MD is actively involved in neuroendocrine cancer research.

Research interests:

Clinical trials, epidemiology, immunotherapy

Subspecialty areas:

  • Lung NETs
  • GI NETs
  • Pancreatic NETs

NET-related professional association memberships:

  • North American Neuroendocrine Tumor Society (NANETS)
  • NCCN NET Guidelines Panel Member

Leadership role(s):

  • North American Neuroendocrine Tumor Society (NANETS)

NETRF Presentations by Daniel Halperin, MD

NETRF news stories including Daniel Halperin, MD

NETRF Awards Six Grants

NETRF awarded six new research grants totaling $1.85 million to leading academic institutions around the world. The goal of the funding is to improve current treatments for neuroendocrine tumors (NETs), an uncommon and poorly understood cancer, which occurs in the body’s hormone-producing cells.